<VariationArchive VariationID="1076006" VariationName="NM_000088.4(COL1A1):c.288del (p.Asp97fs)" VariationType="Deletion" Accession="VCV001076006" Version="10" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-10" DateCreated="2021-05-10" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1064308" VariationID="1076006">
      <GeneList>
        <Gene Symbol="COL1A1" FullName="collagen type I alpha 1 chain" GeneID="1277" HGNC_ID="HGNC:2197" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="50184101" stop="50201631" display_start="50184101" display_stop="50201631" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="48261456" stop="48278999" display_start="48261456" display_stop="48278999" Strand="-" />
          </Location>
          <OMIM>120150</OMIM>
          <Haploinsufficiency last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-08-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000088.4(COL1A1):c.288del (p.Asp97fs)</Name>
      <CanonicalSPDI>NC_000017.11:50199762:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="50199763" stop="50199763" display_start="50199763" display_stop="50199763" variantLength="1" positionVCF="50199762" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="48277124" stop="48277124" display_start="48277124" display_stop="48277124" variantLength="1" positionVCF="48277123" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>D97fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.48277127del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.48277127del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.50199766del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.50199766del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007400.1" sequenceAccession="NG_007400" sequenceVersion="1" change="g.6877del">
            <Expression>NG_007400.1:g.6877del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000088.4" sequenceAccession="NM_000088" sequenceVersion="4" change="c.288del" MANESelect="true">
            <Expression>NM_000088.4:c.288del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000079.2" sequenceAccession="NP_000079" sequenceVersion="2" change="p.Asp97fs">
            <Expression>NP_000079.2:p.Asp97fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1" sequenceAccession="LRG_1">
            <Expression>LRG_1:g.6877del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1t1" sequenceAccession="LRG_1t1">
            <Expression>LRG_1t1:c.288del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2144593759" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000088.4(COL1A1):c.288del (p.Asp97fs) AND Osteogenesis imperfecta type I" Accession="RCV001389739" Version="6">
        <ClassifiedConditionList TraitSetID="5688">
          <ClassifiedCondition DB="MedGen" ID="C0023931">Osteogenesis imperfecta type I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000088.4(COL1A1):c.288del (p.Asp97fs) AND multiple conditions" Accession="RCV002499816" Version="1">
        <ClassifiedConditionList TraitSetID="82012">
          <ClassifiedCondition DB="MedGen" ID="C5436842">Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4551623">Ehlers-Danlos syndrome, arthrochalasia type</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0020497">Infantile cortical hyperostosis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0023931">Osteogenesis imperfecta type I</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268362">Osteogenesis imperfecta type III</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268363">Osteogenesis imperfecta with normal sclerae, dominant form</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268358">Osteogenesis imperfecta, perinatal lethal</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0029456">Osteoporosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-11-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000088.4(COL1A1):c.288del (p.Asp97fs) AND Cardiovascular phenotype" Accession="RCV002438893" Version="2">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-29" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-05-10" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30614853</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7942841</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9295084</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9443882</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="82012" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="54784" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OIEDS SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="619115" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1</ElementValue>
                <XRef ID="MONDO:0030854" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">OIEDS1</ElementValue>
                <XRef Type="MIM" ID="619115" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18316" />
                <XRef ID="18316" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C5436842" DB="MedGen" />
              <XRef ID="MONDO:0030854" DB="MONDO" />
              <XRef Type="MIM" ID="619115" DB="OMIM" />
            </Trait>
            <Trait ID="3328" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OI type 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with normal sclerae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type IV</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta with normal sclerae, dominant form</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+4/5459" DB="Genetic Alliance" />
                <XRef ID="205497004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis Imperfecta Type IV</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OSTEOGENESIS IMPERFECTA, TYPE IV, WITH DENTINOGENESIS IMPERFECTA</ElementValue>
                <XRef Type="Allelic variant" ID="120160.0036" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 4</ElementValue>
                <XRef ID="MONDO:0008148" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI4</ElementValue>
                <XRef Type="MIM" ID="166220" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">COL1A1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8696" />
                <XRef ID="8696" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <XRef ID="216820" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0268363" DB="MedGen" />
              <XRef ID="MONDO:0008148" DB="MONDO" />
              <XRef Type="MIM" ID="166220" DB="OMIM" />
            </Trait>
            <Trait ID="5697" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lobstein disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta tarda</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with blue sclerae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lobstein's Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type I</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+1/5454" DB="Genetic Alliance" />
                <XRef ID="385482004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with opalescent teeth</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1 with dentinogenesis imperfecta</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI, TYPE I</ElementValue>
                <XRef Type="MIM" ID="166200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1</ElementValue>
                <XRef ID="MONDO:0008146" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI1</ElementValue>
                <XRef Type="MIM" ID="166200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000260571" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332445" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525779" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561718" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511197" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562498" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521190" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8694" />
                <XRef ID="8694" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="216796" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0023931" DB="MedGen" />
              <XRef ID="MONDO:0008146" DB="MONDO" />
              <XRef Type="MIM" ID="166200" DB="OMIM" />
            </Trait>
            <Trait ID="22045" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Osteoporosis</ElementValue>
                <XRef ID="Osteoporosis/9059" DB="Genetic Alliance" />
                <XRef ID="HP:0000939" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005298" DB="MONDO" />
                <XRef ID="64859006" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11932" />
                <XRef ID="11932" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C0029456" DB="MedGen" />
              <XRef ID="MONDO:0005298" DB="MONDO" />
              <XRef Type="MIM" ID="166710" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000939" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002774" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="3677" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OSTEOGENESIS IMPERFECTA, TYPE II</ElementValue>
                <XRef Type="MIM" ID="166210" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0044" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0047" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0032" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0041" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0070" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0056" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0029" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0053" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0043" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0045" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0031" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0073" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0025" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0029" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0060" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120160.0034" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0025" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0069" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0023" DB="OMIM" />
                <XRef Type="Allelic variant" ID="120150.0039" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta congenita perinatal lethal form</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta congenita</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Vrolik type of osteogenesis imperfecta</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 2</ElementValue>
                <XRef ID="MONDO:0008147" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta, perinatal lethal</ElementValue>
                <XRef ID="205496008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta, dominant perinatal lethal</ElementValue>
                <XRef ID="7134007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI, TYPE II</ElementValue>
                <XRef Type="MIM" ID="166210" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI2</ElementValue>
                <XRef Type="MIM" ID="166210" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">OIC</ElementValue>
                <XRef Type="MIM" ID="166210" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10142" />
                <XRef ID="10142" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <XRef ID="216804" DB="Orphanet" />
              <XRef ID="C0268358" DB="MedGen" />
              <XRef ID="MONDO:0008147" DB="MONDO" />
              <XRef Type="MIM" ID="166210" DB="OMIM" />
            </Trait>
            <Trait ID="3679" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 3</ElementValue>
                <XRef ID="MONDO:0009804" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta, progressively deforming with normal sclerae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type III</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type III</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+3/5458" DB="Genetic Alliance" />
                <XRef ID="385483009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI3</ElementValue>
                <XRef Type="MIM" ID="259420" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">COL1A1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8695" />
                <XRef ID="8695" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="216812" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0268362" DB="MedGen" />
              <XRef ID="MONDO:0009804" DB="MONDO" />
              <XRef Type="MIM" ID="259420" DB="OMIM" />
            </Trait>
            <Trait ID="4718" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Caffey Disease</ElementValue>
                <XRef ID="NBK99168" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Infantile cortical hyperostosis</ElementValue>
                <XRef ID="24752008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperostosis, Cortical, Congenital</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">P1PK BLOOD GROUP SYSTEM, P(2) PHENOTYPE</ElementValue>
                <XRef Type="Allelic variant" ID="607922.0007" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">COL1A1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Caffey disease is characterized by massive subperiosteal new bone formation (usually involving the diaphyses of the long bones as well as the ribs, mandible, scapulae, and clavicles) typically associated with fever, joint swelling, and pain in children, with onset between birth and five months and spontaneous resolution by age two years. Episodes of recurrence of the manifestations of Caffey disease have been reported multiple times in individuals with the classic infantile presentation. Limited follow-up information suggests that adults who had Caffey disease in childhood may manifest joint laxity, skin hyperextensibility, hernias, short stature, and an increased risk for bone fractures and/or deformities.</Attribute>
                <XRef ID="NBK99168" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1051" />
                <XRef ID="1051" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22855962</ID>
                <ID Source="BookShelf">NBK99168</ID>
              </Citation>
              <XRef ID="1310" DB="Orphanet" />
              <XRef ID="C0020497" DB="MedGen" />
              <XRef ID="MONDO:0007244" DB="MONDO" />
              <XRef Type="MIM" ID="114000" DB="OMIM" />
            </Trait>
            <Trait ID="5008" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Arthrochalasis multiplex congenita</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome type 7A (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EDS7A (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome type 7B (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EDS7B (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome, arthrochalasia type, 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome, arthrochalasis type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ehlers-Danlos syndrome, arthrochalasia type</ElementValue>
                <XRef ID="MONDO:0007525" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EDS VII, MUTANT PROCOLLAGEN TYPE</ElementValue>
                <XRef Type="MIM" ID="130060" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EDS VIIA</ElementValue>
                <XRef Type="MIM" ID="130060" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EDS7A</ElementValue>
                <XRef Type="MIM" ID="130060" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">COL1A1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EDSARTH1</ElementValue>
                <XRef Type="MIM" ID="130060" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2084" />
                <XRef ID="2084" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987428</ID>
              </Citation>
              <XRef ID="1899" DB="Orphanet" />
              <XRef ID="99875" DB="Orphanet" />
              <XRef ID="99876" DB="Orphanet" />
              <XRef ID="C4551623" DB="MedGen" />
              <XRef ID="MONDO:0007525" DB="MONDO" />
              <XRef Type="MIM" ID="130060" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5688" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5697" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lobstein disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta tarda</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with blue sclerae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lobstein's Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type I</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+1/5454" DB="Genetic Alliance" />
                <XRef ID="385482004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with opalescent teeth</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1 with dentinogenesis imperfecta</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI, TYPE I</ElementValue>
                <XRef Type="MIM" ID="166200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1</ElementValue>
                <XRef ID="MONDO:0008146" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI1</ElementValue>
                <XRef Type="MIM" ID="166200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000260571" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332445" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525779" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561718" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511197" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562498" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521190" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8694" />
                <XRef ID="8694" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="216796" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0023931" DB="MedGen" />
              <XRef ID="MONDO:0008146" DB="MONDO" />
              <XRef Type="MIM" ID="166200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5465164" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000088.4:c.288del|OMIM:114000;130060;166200;166210;166220;166710;259420;619115" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002805063" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000088.4:c.288del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="114000" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="130060" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166200" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166210" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166220" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="166710" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="259420" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="619115" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3116868" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11706132|MedGen:C0023931" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001591192" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7942841</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9295084</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9443882</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asp97Thrfs*168) in the COL1A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL1A1 are known to be pathogenic (PMID: 7942841, 9295084, 9443882). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1076006). This premature translational stop signal has been observed in individual(s) with osteogenesis imperfecta (Invitae). This variant is not present in population databases (gnomAD no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.48277124del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023931" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5235108" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a8297750|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002749635" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30614853</ID>
          </Citation>
          <Comment>The c.288delC pathogenic mutation, located in coding exon 2 of the COL1A1 gene, results from a deletion of one nucleotide at nucleotide position 288, causing a translational frameshift with a predicted alternate stop codon (p.D97Tfs*168). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000088.3:c.288delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5465164" TraitType="Disease" MappingType="XRef" MappingValue="166210" MappingRef="OMIM">
        <MedGen CUI="C0268358" Name="Osteogenesis imperfecta, perinatal lethal" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5465164" TraitType="Disease" MappingType="XRef" MappingValue="259420" MappingRef="OMIM">
        <MedGen CUI="C0268362" Name="Osteogenesis imperfecta type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5465164" TraitType="Disease" MappingType="XRef" MappingValue="166200" MappingRef="OMIM">
        <MedGen CUI="C0023931" Name="Osteogenesis imperfecta type I" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5465164" TraitType="Disease" MappingType="XRef" MappingValue="619115" MappingRef="OMIM">
        <MedGen CUI="C5436842" Name="Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5465164" TraitType="Disease" MappingType="XRef" MappingValue="130060" MappingRef="OMIM">
        <MedGen CUI="C4551623" Name="Ehlers-Danlos syndrome, arthrochalasia type" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5465164" TraitType="Disease" MappingType="XRef" MappingValue="166220" MappingRef="OMIM">
        <MedGen CUI="C0268363" Name="Osteogenesis imperfecta with normal sclerae, dominant form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5465164" TraitType="Disease" MappingType="XRef" MappingValue="114000" MappingRef="OMIM">
        <MedGen CUI="C0020497" Name="Infantile cortical hyperostosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3116868" TraitType="Disease" MappingType="XRef" MappingValue="C0023931" MappingRef="MedGen">
        <MedGen CUI="C0023931" Name="Osteogenesis imperfecta type I" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5465164" TraitType="Disease" MappingType="XRef" MappingValue="166710" MappingRef="OMIM">
        <MedGen CUI="C0029456" Name="Osteoporosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5235108" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

